Heat-Not-Burn Tobacco Products: The Devil in Disguise or a Considerable Risk Reduction?

Background: Heat-not-burn (HNB) tobacco products are not burnt but instead are inserted into a tobacco-heating system, which heats the tobacco at temperatures below that required to initiate combustion. This mechanism potentially results in significantly reduced concentrations of heat-generated toxicants in the inhalable aerosol.Method: The margin of exposure (MOE) approach was applied for quantitative risk assessment. The MOE is defined as the ratio between the toxicological threshold and the estimated human intake of the same compound. The higher the MOE, the lower the risk of a compound.Findings: The MOEs were increased by factors of 3 to 415 for the most toxic compounds in tobacco smoke, comparing use of HNB with smoking conventional tobacco products. The combined MOE for all compounds was increased 23-fold, excluding nicotine, or 10-fold including nicotine. Thus, the overall risk for cumulative toxic effects was markedly lower for HNB products.Conclusions: HNB tobacco reduced the risk of exposure to 9 out of the 20 most toxic compounds in tobacco beyond an MOE threshold of 10,000. While our results show that use of HNB products leads to a considerable risk reduction compared to conventional tobacco, the products cannot be considered completely “risk-free” due to risk of exposure to the remaining toxicants with MOE below the threshold.

[1]  H. Hou,et al.  Chemical Analysis and Simulated Pyrolysis of Tobacco Heating System 2.2 Compared to Conventional Cigarettes , 2019, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[2]  A. Luch,et al.  Levels of selected analytes in the emissions of “heat not burn” tobacco products that are relevant to assess human health risks , 2018, Archives of Toxicology.

[3]  Rémi H. J. Dulize,et al.  A 90-day OECD TG 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects of the aerosol from the carbon heated tobacco product version 1.2 (CHTP1.2) compared with cigarette smoke. II. Systems toxicology assessment. , 2018, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[4]  S. Gallus,et al.  Heat-Not-Burn Tobacco Products Are Getting Hot in Italy , 2018, Journal of epidemiology.

[5]  M. Peitsch,et al.  A 90-day OECD TG 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects of the aerosol from the carbon heated tobacco product version 1.2 (CHTP1.2) compared with cigarette smoke. I. Inhalation exposure, clinical pathology and histopathology. , 2018, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[6]  P. Talbot,et al.  iQOS: evidence of pyrolysis and release of a toxicant from plastic , 2018, Tobacco Control.

[7]  S. McGrath-Morrow,et al.  Heat-not-Burn Tobacco Products: Tobacco Industry Claims No Substitute for Science , 2018, Pediatrics.

[8]  M. Peitsch,et al.  Perplexing Conclusions Concerning Heat-Not-Burn Tobacco Cigarettes. , 2017, JAMA internal medicine.

[9]  A. Kondylis,et al.  Comparative assessment of HPHC yields in the Tobacco Heating System THS2.2 and commercial cigarettes , 2017, Regulatory toxicology and pharmacology : RTP.

[10]  R. Weitkunat,et al.  Nicotine pharmacokinetic profiles of the Tobacco Heating System 2.2, cigarettes and nicotine gum in Japanese smokers , 2017, Regulatory toxicology and pharmacology : RTP.

[11]  W. E. Stephens Comparing the cancer potencies of emissions from vapourised nicotine products including e-cigarettes with those of tobacco smoke , 2017, Tobacco Control.

[12]  R. Auer,et al.  Heat-Not-Burn Tobacco Cigarettes: Smoke by Any Other Name , 2017, JAMA internal medicine.

[13]  M. Peitsch,et al.  Evaluation of the Tobacco Heating System 2.2. Part 1: Description of the system and the scientific assessment program. , 2016, Regulatory toxicology and pharmacology : RTP.

[14]  P. Vanscheeuwijck,et al.  Evaluation of the Tobacco Heating System 2.2. Part 2: Chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol. , 2016, Regulatory toxicology and pharmacology : RTP.

[15]  J. Rehm,et al.  Comparative risk assessment of tobacco smoke constituents using the margin of exposure approach: the neglected contribution of nicotine , 2016, Scientific Reports.

[16]  H. Tomioka,et al.  Acute eosinophilic pneumonia following heat‐not‐burn cigarette smoking , 2016, Respirology case reports.

[17]  Theodore L. Caputi Industry watch: heat-not-burn tobacco products are about to reach their boiling point , 2016, Tobacco Control.

[18]  M. Peitsch,et al.  Effects of Cigarette Smoke, Cessation, and Switching to Two Heat-Not-Burn Tobacco Products on Lung Lipid Metabolism in C57BL/6 and Apoe−/− Mice—An Integrative Systems Toxicology Analysis , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[19]  R. Weitkunat,et al.  Comparison of the Pharmacokinetics of Nicotine Following Single and Ad Libitum Use of a Tobacco Heating System or Combustible Cigarettes , 2015, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[20]  J. Rehm,et al.  Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach , 2015, Scientific Reports.

[21]  D. Lachenmeier,et al.  Electronic cigarettes: overview of chemical composition and exposure estimation , 2014, Tobacco induced diseases.

[22]  Opinion of the Scientific Committee on a request from EFSA related to A Harmonised Approach for Risk Assessment of Substances Which are both Genotoxic and Carcinogenic (Request No EFSA-Q-2004-020) , 2005 .